Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001789617-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Jan 31, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
103,070
Total Value
$234,797.20
P&L
+inf% (+$2,654,467.20)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF COMMERCIAL OFFICER | Common Stock | โ | Jan 31, 2026 | Grant/Award | 26,120 | $0.00 | $0.00 | 139,133 | Direct | โ | View Details | |
CHIEF COMMERCIAL OFFICER | Common Stock | โ | Feb 3, 2026 | Sale | 7,310 | $32.12 | $234,797.20 | 131,823 | Direct | โ | View Details | |
CHIEF COMMERCIAL OFFICER | Employee stock option (right to buy) | Derivative | Jan 31, 2026 | Grant/Award | 69,640 | $0.00 | $0.00 | 69,640 | Direct | โ | View Details |